Stocks · Health care · Pharmaceutical Preparations

iBio, Inc.

IBIO Clue Score37
United States Fiscal year ends June CIK 0001420720 Results filed 28 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Marc Banjak
26 Mar 2026
Chief Legal Officer
Buy
1,434
$1.76
$2.52K
Marc Banjak
26 Mar 2026
Chief Legal Officer
Buy
12,500
$1.64
$20.53K
Martin Brenner
19 Mar 2026
See Remarks
Buy
12,336
$2.02
$24.92K
Felipe Duran
19 Mar 2026
Chief Financial Officer
Buy
24,835
$2.02
$50.13K
Gary Sender
10 Jan 2025
Director
Buy
9,191
$2.72
$25.00K
Antonio Bernardino Guimaraes Parada
10 Jan 2025
Director
Buy indirect
183,823
$2.72
$500.00K
William D Clark
10 Jan 2025
Director
Buy
1,838
$2.72
$5.00K
David Arkowitz
10 Jan 2025
Director
Buy
18,382
$2.72
$50.00K
Marc Banjak
10 Jan 2025
Chief Legal Officer
Buy
9,191
$2.72
$25.00K
Martin Brenner
10 Jan 2025
See Remarks
Buy
9,191
$2.72
$25.00K
Felipe Duran
10 Jan 2025
Chief Financial Officer
Buy
9,191
$2.72
$25.00K
Eastern Capital LTD
12 Jul 2018
10% owner
Buy
2,200,000
$0.90
$1.98M
Eastern Capital LTD
26 Jun 2018
10% owner
Buy
1,683,334
$0.90
$1.52M
Eastern Capital LTD
30 Nov 2017
10% owner
Buy
12,000,000
$0.20
$2.40M
Kenneth Bryan Dart
23 Feb 2017
10% owner
Buy indirect
1
—
no price

What was left out

Form 4 filings counted 139
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 4
Sales at will 22
Transactions with no price 1
Shares from compensation/vesting 30,466,215
Sales filed before the plan box existed 8
History held since 21 Aug 2008